CAVHANZA vs KOSELUGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CAVHANZA and KOSELUGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	KOSELUGO
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB	SELUMETINIB SULFATE
Manufacturer	Flex Pharma	Astrazeneca
Dosage forms	Tablet, orally disintegrating	Capsule, Powder
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Neurofibromatosis 1

cavhanza koselugo

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

NILOTINIB

SELUMETINIB SULFATE

Manufacturer

Flex Pharma

Astrazeneca

Dosage forms

Tablet, orally disintegrating

Capsule, Powder

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Neurofibromatosis 1

Frequently asked questions

What is the difference between Cavhanza and Koselugo?

Cavhanza contains Nilotinib, while Koselugo contains Selumetinib Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.